February 21, 2013 /
Additional MS resource sites
Signs of Multiple Sclerosis Relapse
What Happens During a Relapse?
When you experience a multiple sclerosis relapse (also known as an exacerbation or flare-up), it’s because new damage in your brain or spinal cord disrupts nerve signals. That’s why you might notice new symptoms or the return of old symptoms. A true relapse lasts more than 24 hours and happens at least 30 days after any previous relapses. Relapses vary in length, severity, and symptoms. Over time, your symptoms should improve. Many people recover from their relapses without treatment.

Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
Stay informed with MS news and information - Sign-up here
For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY CHAT
Categories
Latest Blog Posts
- Genentech’s Fenebrutinib Shows Unprecedented Positive Phase III Results as the Potential First and Only BTK Inhibitor in Both Relapsing and Primary Progressive Multiple Sclerosis
- UIC Study: Remote Pilates Program for People Living with MS
- Exercise and Cognition in Multiple Sclerosis in 2025: Forward Momentum or Going Nowhere Fast?
- Safety, adherence, and compliance in a RCT of supervised exercise training among persons with multiple sclerosis who have slowed cognitive processing speed
- Trigeminal neuralgia and MS
- What Is an MS Zinger and How Can You Manage It?
- What to know about itching and MS
- Two compounds with potential for myelin repair in MS identified
- Losing my sense of safety after an MS relapse
- 7 Ways to Navigate Your Health Insurance With MS
- Big Changes Are Coming for 2026 Medicare Plans. What You Need to Know.
- Exercise in MS eases fatigue, improves muscular fitness: Analysis
- Could Ultra-Processed Foods Make Your MS Worse?
- VIRTUAL Physical Therapy – (each month) – “MOVING WITH MS” –
- The New MS Diagnostic Criteria: What You Need To Know
- Octave wins grant to develop blood test for measuring MS progression
- With new data, Quantum moves closer to launching trial of Lucid-MS – a potential treatment for targeting demyelination
- When living with MS, we have to be open to change in our routine
- ECTRIMS 2025: Immunic chief medical officer discusses vidofludimus calcium for MS
- ECTRIMS 2025: Medical director at Genentech discusses potential of Ocrevus as a pediatric MS treatment
